ACXP

ACURX PHARMACEUTICALS INC

ACXP·00510M104·UQ·Common Stock·Healthcare - Biotechnology

ACXP (ACURX PHARMACEUTICALS INC) is held by 12 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($48,203), GEODE CAPITAL MANAGEMENT, LLC ($40,938), VANGUARD FIDUCIARY TRUST CO ($25,118). Net institutional sentiment: Mixed.

12
Holders
$154,662
Total Value
38% (8)
Consensus
3 buying - 5 selling
13F: Insider & Congress: Updated regularly
ACXP

Smart Money Verdict

View all
Loading verdict
Held by 12 funds

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for ACXP.

Top Holders

Checking access…
Action
Unchanged
31,099$48,2030.0%-25.68%
0
Increased
26,411(+6.4%)$40,9380.0%-64.14%
15
Unchanged
16,205$25,1180.0%-25.68%
0
Decreased
15,727(-71.2%)$24,3770.0%-68.53%
0
Increased
7,500(+15.4%)$11,6250.0%-66.27%
14
Unchanged
2,300$3,5650.0%-58.02%
0
Decreased
281(-26.1%)$4360.0%-25.68%
0
Unchanged
100$1550.0%-74.30%
0
Decreased
95(-61.2%)$1470.0%-70.94%
0
Unchanged
60$930.0%-70.48%
0
Decreased
3(-100.0%)$50.0%-70.12%
0
Exited
0(-100.0%)$40.0%-63.79%
0
New
0$00.0%-29.03%
17
ACXPACXPACURX PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used